Thomas K.

Thomas K. has a robust work experience in the finance field. Thomas started their career at Madison Gas and Electric as an Accounting Analyst, where they worked from 2005 to 2008. Thomas then moved on to Roche, where they worked as a Finance Manager for Strategy and Long Term Planning from 2008 to 2014. After that, they joined Relypsa as an Associate Director of FP&A, focusing on Manufacturing and Logistics, until 2018. From there, they joined Tricida, Inc. as the Director of FP&A, but their tenure lasted only until November 2018. Following this, they worked at Assembly Biosciences, Inc. as an Associate Director of FP&A from 2019 to 2021. Recently, they held the position of Director of Finance at Mirati Therapeutics until April 2023. Thomas is currently working as the Director of Finance at Cerevel Therapeutics.

Thomas K. attended the Wisconsin School of Business from 2002 to 2004, where they pursued a Bachelor of Business Administration (BBA) degree with a specialization in Accounting.